Trial Profile
Efficacy and Safety of Voriconazole for Treatment of Invasive Pulmonary Aspergillosis Secondary to COPD: a Multi-center Prospective Open Cohort Study (VIA-COPD)
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 30 Sep 2022
Price :
$35
*
At a glance
- Drugs Voriconazole (Primary)
- Indications Aspergillosis
- Focus Therapeutic Use
- Acronyms VIA-COPD
- 12 Sep 2014 New trial record